nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Bronchospasm—Pentoxifylline—systemic scleroderma	0.0281	0.0281	CcSEcCtD
Bromhexine—Bronchospasm—Mometasone—systemic scleroderma	0.0242	0.0242	CcSEcCtD
Bromhexine—Bronchospasm—Captopril—systemic scleroderma	0.0213	0.0213	CcSEcCtD
Bromhexine—Immune system disorder—Pentoxifylline—systemic scleroderma	0.0206	0.0206	CcSEcCtD
Bromhexine—Angioedema—Pentoxifylline—systemic scleroderma	0.0182	0.0182	CcSEcCtD
Bromhexine—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.018	0.018	CcSEcCtD
Bromhexine—Immune system disorder—Mometasone—systemic scleroderma	0.0178	0.0178	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.0168	0.0168	CcSEcCtD
Bromhexine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.0162	0.0162	CcSEcCtD
Bromhexine—Skin disorder—Pentoxifylline—systemic scleroderma	0.0158	0.0158	CcSEcCtD
Bromhexine—Angioedema—Mometasone—systemic scleroderma	0.0157	0.0157	CcSEcCtD
Bromhexine—Bronchospasm—Lisinopril—systemic scleroderma	0.0151	0.0151	CcSEcCtD
Bromhexine—Anaphylactic shock—Mometasone—systemic scleroderma	0.014	0.014	CcSEcCtD
Bromhexine—Angioedema—Captopril—systemic scleroderma	0.0138	0.0138	CcSEcCtD
Bromhexine—Immune system disorder—Azathioprine—systemic scleroderma	0.0137	0.0137	CcSEcCtD
Bromhexine—Urticaria—Pentoxifylline—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Bromhexine—Immune system disorder—Leflunomide—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Bromhexine—Anaphylactic shock—Captopril—systemic scleroderma	0.0123	0.0123	CcSEcCtD
Bromhexine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.012	0.012	CcSEcCtD
Bromhexine—Pruritus—Pentoxifylline—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Bromhexine—Angioedema—Leflunomide—systemic scleroderma	0.0114	0.0114	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Bromhexine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.0105	0.0105	CcSEcCtD
Bromhexine—Skin disorder—Azathioprine—systemic scleroderma	0.0104	0.0104	CcSEcCtD
Bromhexine—Vomiting—Pentoxifylline—systemic scleroderma	0.0103	0.0103	CcSEcCtD
Bromhexine—Rash—Pentoxifylline—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Bromhexine—Dermatitis—Pentoxifylline—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Bromhexine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.01	0.01	CcSEcCtD
Bromhexine—Pruritus—Mometasone—systemic scleroderma	0.00991	0.00991	CcSEcCtD
Bromhexine—Skin disorder—Leflunomide—systemic scleroderma	0.00985	0.00985	CcSEcCtD
Bromhexine—Angioedema—Lisinopril—systemic scleroderma	0.00976	0.00976	CcSEcCtD
Bromhexine—Nausea—Pentoxifylline—systemic scleroderma	0.00965	0.00965	CcSEcCtD
Bromhexine—Diarrhoea—Mometasone—systemic scleroderma	0.00959	0.00959	CcSEcCtD
Bromhexine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.0094	0.0094	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00927	0.00927	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00903	0.00903	CcSEcCtD
Bromhexine—Vomiting—Mometasone—systemic scleroderma	0.00891	0.00891	CcSEcCtD
Bromhexine—Rash—Mometasone—systemic scleroderma	0.00883	0.00883	CcSEcCtD
Bromhexine—Dermatitis—Mometasone—systemic scleroderma	0.00883	0.00883	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00876	0.00876	CcSEcCtD
Bromhexine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00872	0.00872	CcSEcCtD
Bromhexine—Pruritus—Captopril—systemic scleroderma	0.00871	0.00871	CcSEcCtD
Bromhexine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00855	0.00855	CcSEcCtD
Bromhexine—Skin disorder—Lisinopril—systemic scleroderma	0.00847	0.00847	CcSEcCtD
Bromhexine—Diarrhoea—Captopril—systemic scleroderma	0.00842	0.00842	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00835	0.00835	CcSEcCtD
Bromhexine—Nausea—Mometasone—systemic scleroderma	0.00832	0.00832	CcSEcCtD
Bromhexine—Urticaria—Leflunomide—systemic scleroderma	0.00806	0.00806	CcSEcCtD
Bromhexine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00791	0.00791	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00791	0.00791	CcSEcCtD
Bromhexine—Vomiting—Captopril—systemic scleroderma	0.00782	0.00782	CcSEcCtD
Bromhexine—Rash—Captopril—systemic scleroderma	0.00776	0.00776	CcSEcCtD
Bromhexine—Dermatitis—Captopril—systemic scleroderma	0.00775	0.00775	CcSEcCtD
Bromhexine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00764	0.00764	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00752	0.00752	CcSEcCtD
Bromhexine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00747	0.00747	CcSEcCtD
Bromhexine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00742	0.00742	CcSEcCtD
Bromhexine—Diarrhoea—Azathioprine—systemic scleroderma	0.00735	0.00735	CcSEcCtD
Bromhexine—Nausea—Captopril—systemic scleroderma	0.00731	0.00731	CcSEcCtD
Bromhexine—Pruritus—Leflunomide—systemic scleroderma	0.00718	0.00718	CcSEcCtD
Bromhexine—Diarrhoea—Leflunomide—systemic scleroderma	0.00694	0.00694	CcSEcCtD
Bromhexine—Urticaria—Lisinopril—systemic scleroderma	0.00692	0.00692	CcSEcCtD
Bromhexine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00685	0.00685	CcSEcCtD
Bromhexine—Vomiting—Azathioprine—systemic scleroderma	0.00683	0.00683	CcSEcCtD
Bromhexine—Rash—Azathioprine—systemic scleroderma	0.00677	0.00677	CcSEcCtD
Bromhexine—Dermatitis—Azathioprine—systemic scleroderma	0.00677	0.00677	CcSEcCtD
Bromhexine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00662	0.00662	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00659	0.00659	CcSEcCtD
Bromhexine—Immune system disorder—Prednisone—systemic scleroderma	0.00658	0.00658	CcSEcCtD
Bromhexine—Vomiting—Leflunomide—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Bromhexine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00642	0.00642	CcSEcCtD
Bromhexine—Rash—Leflunomide—systemic scleroderma	0.0064	0.0064	CcSEcCtD
Bromhexine—Dermatitis—Leflunomide—systemic scleroderma	0.00639	0.00639	CcSEcCtD
Bromhexine—Nausea—Azathioprine—systemic scleroderma	0.00638	0.00638	CcSEcCtD
Bromhexine—Pruritus—Lisinopril—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Bromhexine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00615	0.00615	CcSEcCtD
Bromhexine—Rash—Mycophenolic acid—systemic scleroderma	0.0061	0.0061	CcSEcCtD
Bromhexine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0061	0.0061	CcSEcCtD
Bromhexine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00607	0.00607	CcSEcCtD
Bromhexine—Nausea—Leflunomide—systemic scleroderma	0.00602	0.00602	CcSEcCtD
Bromhexine—Diarrhoea—Lisinopril—systemic scleroderma	0.00596	0.00596	CcSEcCtD
Bromhexine—Angioedema—Prednisone—systemic scleroderma	0.0058	0.0058	CcSEcCtD
Bromhexine—Nausea—Mycophenolic acid—systemic scleroderma	0.00575	0.00575	CcSEcCtD
Bromhexine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00563	0.00563	CcSEcCtD
Bromhexine—Vomiting—Lisinopril—systemic scleroderma	0.00554	0.00554	CcSEcCtD
Bromhexine—Immune system disorder—Methotrexate—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Bromhexine—Rash—Lisinopril—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Bromhexine—Dermatitis—Lisinopril—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Bromhexine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0054	0.0054	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Bromhexine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00522	0.00522	CcSEcCtD
Bromhexine—Nausea—Lisinopril—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Bromhexine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Bromhexine—Skin disorder—Prednisone—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Bromhexine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00486	0.00486	CcSEcCtD
Bromhexine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Bromhexine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Bromhexine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Bromhexine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Bromhexine—Skin disorder—Methotrexate—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Bromhexine—Urticaria—Prednisone—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Bromhexine—Hypersensitivity—Prednisone—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Bromhexine—Pruritus—Prednisone—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Bromhexine—Diarrhoea—Prednisone—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Bromhexine—Urticaria—Methotrexate—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Bromhexine—Vomiting—Prednisone—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Bromhexine—Rash—Prednisone—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Bromhexine—Dermatitis—Prednisone—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Bromhexine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Bromhexine—Nausea—Prednisone—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Bromhexine—Pruritus—Methotrexate—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Bromhexine—Diarrhoea—Methotrexate—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Bromhexine—Vomiting—Methotrexate—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Bromhexine—Rash—Methotrexate—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Bromhexine—Dermatitis—Methotrexate—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Bromhexine—Nausea—Methotrexate—systemic scleroderma	0.00257	0.00257	CcSEcCtD
